Skip to content

Incidence of Recall After Procedural Sedation With Propofol in the Emergency Department

Incidence of Recall After Procedural Sedation With Propofol in the Emergency Department

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02200744
Acronym
MEMOPROPO
Enrollment
248
Registered
2014-07-25
Start date
2014-07-30
Completion date
2018-09-20
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fractures Reduction, Joint Dislocation Reduction

Keywords

Procedural sedation, emergency department, adults, propofol, recall assessment

Brief summary

The purpose of this study is to determine the incidence of recall in patients managed in emergency department with a procedural sedation protocol using propofol in a population of 250 .

Detailed description

After procedural sedation for fracture or joint dislocation reduction using propofol, adult patients recall will be assessed with a standardised form. This recall assessment will be realised 2 hours (+/- 15 minutes) after the procedural sedation and the day after. The primary outcome measure will be the recall incidence 2 hours (+/- 15 minutes) after a procedural sedation. A secondary outcome will be the recall incidence one day after the procedural sedation. The recall will be defined by a positive answer to the third question of the Sandin form (Lancet. 2000;355(9205):707-11).

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de la Réunion
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults patients (\> 18 years old) who had a procedural sedation in emergency department using propofol for fracture or joint dislocation reduction * Patients who received an initial injection of Propofol by slow intravenous injection of 1 mg/kg in 20 seconds * Inclusion less than 2 hours from the injection of Propofol * Patients who have signed a consent to participate in the study * Patients covered by social security.

Exclusion criteria

* Patients under 18 years old * Patients who cannot signed the informed consent * Patients who had procedural sedation using other drugs that propofol * Participation in another study type biomedical research

Design outcomes

Primary

MeasureTime frameDescription
Recall incidenceAt 2 hours (+/- 15 minutes) after procedural sedation with propofolquestionnaire of Brice amended by Sandin

Secondary

MeasureTime frameDescription
Recall incidenceAbout 24 hours after procedural sedation with propofolThe patient will be contacted by phone the next day after procedural sedation with propofol. They will answer the questionnaire of Brice amended by Sandin
Patient's satisfaction assessmentAt 2 hours (+/- 15 minutes) after procedural sedation with propofolnumerical verbal scale

Countries

France

Contacts

PRINCIPAL_INVESTIGATORPierre-Jean Marianne, MD

CHU de La Réunion

PRINCIPAL_INVESTIGATORMarc Weber, MD

Groupe Hospitalier Est Réunion

PRINCIPAL_INVESTIGATORKatia Mougin, MD

Centre Hospitalier Gabriel Martin

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026